Sara Tabatabai

9PUBLICATIONS
46CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersPharmacology and pharmaceutical sciences not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Dec 11, 2025
Clinician- and Facility-Level Factors Associated With Receipt of Nonguideline Chemotherapy Regimens in Women With Stage I-IIIA Breast Cancer.

Yashasvini Sampathkumar, Ziad Zakaria, Kelli O'Connell

|Nov 05, 2025
Provider billing margin and cancer treatment selection: population based cohort study.

Aaron P Mitchell, Stacie B Dusetzina, Akriti Mishra Meza

|Sep 05, 2025
Changes in Cost of Guideline-Concordant Cancer Treatment: Observations and Implications.

Judy J Wang, Sonia Persaud, Sara Tabatabai

|Feb 14, 2025
Methodologic Approach to Defining Comorbidities in a Cohort of Patients With Cancer: An Example in the Optimal Breast Cancer Chemotherapy Dosing Study.

Peng Wang, Kelli O'Connell, Jenna Bhimani

|Nov 26, 2024
Trends in enforcement of National Comprehensive Cancer Network financial conflict of interest policy.

Niloufar Saririan, Dedipya Bhamidipati, Pranam Dey

|Oct 11, 2024
Quality of Treatment Selection for Medicare Beneficiaries With Cancer.

Aaron P Mitchell, Sonia Persaud, Akriti Mishra Meza

Pageof 2

Frequent Collaborators

8 joint publications

Sonia Persaud

6 joint publications

Grace Gallagher

5 joint publications

Aaron Philip Mitchell

5 joint publications

Victoria S Blinder